Care Access Research - Youngstown

Poland, Ohio 44514

0 studies enrolling now · 1 studies all time

What they study most

Ulcerative Colitis

Studies at this site

• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed